Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 12.30
0.00 (0.00%)
Aug 4, 2026, 1:22 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 569.03 million as of August 4, 2026. Its market cap has increased by 11.11% in one year.
Market Cap
569.03M
Enterprise Value
399.17M
Revenue
61.41M
Ranking
n/a
PE Ratio
5.94
Stock Price
12.30
ChartMarket Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 569.03M, an increase of 44.70%. That is a compound annual growth rate of 2.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 569.03M | -7.14% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 953.21M |
| TCI GENE | 899.59M |
| Meribank Biotech | 872.42M |
| Taiwan Advance Bio-Pharmaceutical | 822.60M |
| NatureWise Biotech & Medicals | 762.33M |
| BioLASCO Taiwan | 760.68M |
| Neith | 710.20M |
| SynCore Biotechnology Co.,Ltd | 689.22M |